Drugs with carcinogenic toxins: banned elsewhere, sold in India17 min read 15 Aug 2021, 10:38 PM IST
The detection of carcinogenic compounds in commonly used drugs has plunged the global pharma industry into crisis mode. India’s drug regulator has done little to protect citizens
Elsewhere in the world, the findings have been followed by recalls and suspension of sales of contaminated batches. In India, however, the pharma industry has been left to its own devices
In 2019, Asha’s toddler son had a bout of illness. The three-year old would frequently vomit while at the day-care facility he attended, and refuse to eat lunch. Asha, who works at a medical-diagnostic chain in Mumbai, approached her trusted paediatrician. His investigations revealed that the child had gastroesophageal reflux disease—a condition in which stomach acid travels up the food pipe, causing pain and nausea.
Select your Category